Rapid Assessment of T-Cell Receptor Specificity of the Immune Repertoire

Xingcheng Lin1,2,3, Jason T George1,4, Nicholas P Schafer1,5

  • 1Center for Theoretical Biological Physics, Rice University, Houston, TX.

Nature Computational Science
|September 12, 2022
PubMed

Insights

A new model called RACER rapidly assesses T-cell receptor (TCR) and peptide binding affinity. This computational tool aids in identifying tumor antigen-specific T-cells for personalized cancer immunotherapy.

Area of Science:

  • Immunology
  • Computational Biology
  • Bioinformatics

Background:

  • Accurate assessment of T-cell receptor (TCR)-antigen specificity is crucial for advancing cancer immunotherapy.
  • Existing predictive models lack the high-throughput capacity for assessing TCR-peptide pairs.
  • Advances in sequencing and crystallography provide rich data for studying TCR-peptide-MHC interactions.

Purpose of the Study:

  • To introduce RACER, a novel pairwise energy model for rapid assessment of TCR-peptide affinity at the immune repertoire level.
  • To develop a supervised machine learning approach for efficiently distinguishing strong TCR-peptide binding pairs from weak ones.
  • To enable physical interpretation of interaction patterns within TCR-p-MHC systems.

Main Methods:

  • Development of RACER, a supervised machine learning model based on a pairwise energy approach.
  • Training the model on existing data to learn TCR-peptide binding characteristics.
  • Application of RACER to simulate thymic selection and estimate recognition rates for various peptides.

Main Results:

  • RACER efficiently and accurately resolves strong TCR-peptide binding pairs from weak ones.
  • The model's trained parameters offer physical insights into TCR-p-MHC system interactions.
  • RACER accurately estimates recognition rates for tumor-associated neoantigens and foreign peptides in simulated thymic selection.

Conclusions:

  • RACER provides a powerful computational tool for high-throughput assessment of TCR-peptide affinity.
  • The model aids in identifying tumor antigen-specific T-cells within an individual patient's immune repertoire.
  • RACER has significant utility for advancing personalized cancer immunotherapy research.